Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
16,869,505
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
1,624,962
-
Shares change
-
+1,624,962
-
Total reported value, excl. options
-
$1,154,593
-
Value change
-
+$1,154,593
-
Number of buys
-
26
-
Price
-
$0.7100
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q1 2023
As of 31 Mar 2023 Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,624,962 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, VANGUARD GROUP INC, Long Focus Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, MATRIX ASSET ADVISORS INC/NY, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Creative Planning.
This table shows 26 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.